Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo
- PMID: 22553319
- PMCID: PMC3416312
- DOI: 10.1128/JVI.00878-12
Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo
Abstract
Human immunodeficiency virus type 1 (HIV-1) Nef downregulates major histocompatibility complex class I (MHC-I), impairing the clearance of infected cells by CD8(+) cytotoxic T lymphocytes (CTLs). While sequence motifs mediating this function have been determined by in vitro mutagenesis studies of laboratory-adapted HIV-1 molecular clones, it is unclear whether the highly variable Nef sequences of primary isolates in vivo rely on the same sequence motifs. To address this issue, nef quasispecies from nine chronically HIV-1-infected persons were examined for sequence evolution and altered MHC-I downregulatory function under Gag-specific CTL immune pressure in vitro. This selection resulted in decreased nef diversity and strong purifying selection. Site-by-site analysis identified 13 codons undergoing purifying selection and 1 undergoing positive selection. Of the former, only 6 have been reported to have roles in Nef function, including 4 associated with MHC-I downregulation. Functional testing of naturally occurring in vivo polymorphisms at the 7 sites with no previously known functional role revealed 3 mutations (A84D, Y135F, and G140R) that ablated MHC-I downregulation and 3 (N52A, S169I, and V180E) that partially impaired MHC-I downregulation. Globally, the CTL pressure in vitro selected functional Nef from the in vivo quasispecies mixtures that predominately lacked MHC-I downregulatory function at the baseline. Overall, these data demonstrate that CTL pressure exerts a strong purifying selective pressure for MHC-I downregulation and identifies novel functional motifs present in Nef sequences in vivo.
Figures






Similar articles
-
Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.J Virol. 2015 Sep;89(18):9639-52. doi: 10.1128/JVI.01548-15. Epub 2015 Jul 15. J Virol. 2015. PMID: 26178998 Free PMC article. Clinical Trial.
-
Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.J Virol. 2017 Dec 14;92(1):e01409-17. doi: 10.1128/JVI.01409-17. Print 2018 Jan 1. J Virol. 2017. PMID: 29046444 Free PMC article.
-
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.PLoS Pathog. 2007 Jul;3(7):e94. doi: 10.1371/journal.ppat.0030094. PLoS Pathog. 2007. PMID: 17616974 Free PMC article.
-
Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?Viruses. 2012 Sep;4(9):1711-30. doi: 10.3390/v4091711. Epub 2012 Sep 24. Viruses. 2012. PMID: 23170180 Free PMC article. Review.
-
HIV immune evasion disruption of antigen presentation by the HIV Nef protein.Adv Virus Res. 2011;80:103-27. doi: 10.1016/B978-0-12-385987-7.00005-1. Adv Virus Res. 2011. PMID: 21762823 Free PMC article. Review.
Cited by
-
Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Expert Rev Anti Infect Ther. 2014 Oct;12(10):1187-201. doi: 10.1586/14787210.2014.956094. Epub 2014 Sep 4. Expert Rev Anti Infect Ther. 2014. PMID: 25189526 Free PMC article. Review.
-
HIV-1 Nef in macrophage-mediated disease pathogenesis.Int Rev Immunol. 2012 Dec;31(6):432-50. doi: 10.3109/08830185.2012.737073. Int Rev Immunol. 2012. PMID: 23215766 Free PMC article. Review.
-
Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.J Virol. 2015 Sep;89(18):9639-52. doi: 10.1128/JVI.01548-15. Epub 2015 Jul 15. J Virol. 2015. PMID: 26178998 Free PMC article. Clinical Trial.
-
In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.Retrovirology. 2015 Jul 14;12:61. doi: 10.1186/s12977-015-0187-z. Retrovirology. 2015. PMID: 26169178 Free PMC article.
-
HIV-1 Nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic T lymphocyte selective pressure.PLoS One. 2013 Sep 13;8(9):e75620. doi: 10.1371/journal.pone.0075620. eCollection 2013. PLoS One. 2013. PMID: 24058696 Free PMC article. Clinical Trial.
References
-
- Ahmad N, Venkatesan S. 1988. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241:1481–1485 - PubMed
-
- Ali A, Jamieson BD, Yang OO. 2003. Half-genome human immunodeficiency virus type 1 constructs for rapid production of reporter viruses. J. Virol. Methods 110:137–142 - PubMed
-
- Ali A, Ng HL, Dagarag MD, Yang OO. 2005. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression. Eur. J. Immunol. 35:3221–3228 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials